| FDA: Blood Pressure Medication Warning - dailyRx |
|
|
dailyRx The labels for the aliskiren drugs are being updated based on preliminary data from a clinical trial, “Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE).” In ALTITUDE, the risks of kidney (renal) impairment, low blood pressure |